
Oncologist

No OPD information available
Astrocytoma
Glioblastoma
Glioma
Brain Tumor
Gliomatosis Cerebri
Cerebral Hypoxia
Colorectal Cancer
Embryonal Tumor with Multilayered Rosettes
Head and Neck Squamous Cell Carcinoma (HNSCC)
Hypophosphatemia
Lung Cancer
Lymphofollicular Hyperplasia
Medullary Thyroid Carcinoma
Medulloblastoma
Mesothelioma
Metastatic Brain Tumor
Neuroendocrine Tumor
Ovarian Cancer
Renal Cell Carcinoma (RCC)
Spinal Tumor
Hui K. Gan is a female doctor who helps people with different types of cancer like brain tumors, lung cancer, and ovarian cancer. She also treats conditions like hypophosphatemia and spinal tumors.
Dr. Gan is very skilled in treating patients with brain tumors like astrocytoma, glioblastoma, and medulloblastoma. She also works with other types of cancer such as colorectal cancer, head and neck squamous cell carcinoma, and renal cell carcinoma.
Dr. Gan is good at talking to her patients and making them feel comfortable. Patients trust her because she listens to their concerns and explains things clearly. She is caring and kind, which helps patients feel safe and supported.
To stay updated with the latest medical knowledge, Dr. Gan reads research papers and attends conferences. This helps her learn about new treatments and techniques so she can provide the best care for her patients.
Dr. Gan works well with other doctors and healthcare professionals. She shares information and collaborates with her colleagues to give patients the best possible care. This teamwork approach ensures that patients receive comprehensive and coordinated treatment.
Dr. Gan's work has had a positive impact on many patients' lives. By providing expert care and support, she helps patients fight their illnesses and improve their health. Her dedication and expertise make a difference in the lives of those she treats.
One of Dr. Gan's notable publications is "Contemporary Patterns of Care for Low-Grade Glioma in Australia and New Zealand," which shows her commitment to advancing cancer care. She has also been involved in clinical trials to test new treatments for advanced solid tumors, demonstrating her dedication to finding better solutions for her patients.
Enrollment Status: Completed
Published: February 28, 2025
Intervention Type: Biological
Study Drug:
Study Phase: Phase 1
